The literature compound 3-hydroxy-bisnor-5-cholenic aldehyde is an important intermediate for the synthesis of new modulators of the nuclear oxysterol receptor Liver X. As part of our ongoing search for new LXR antagonists, the title compound, C 24 H 39 NO 3 , has proven to be an important intermediate in our new synthetic pathway, giving the corresponding aldehyde in high yield and in only three steps from the commercially available 3-hydroxy-bisnor-5-cholenic acid. The title amide crystallized with two molecules in the asymmetric unit, linked into helices by O-HÁ Á ÁO hydrogen bonds involving the hydroxy and carbonyl groups.
Chemical context
In the nuclear receptor (NR) family, the two isoforms of the nuclear oxysterol receptor Liver X (LXR and LXR) are emerging new drug targets. They are key players for a number of important processes related to disease, such as metabolic and cardiovascular diseases, lipid metabolism, inflammation and cancer (Steffensen & Gustafsson, 2006; Laffitte et al., 2003) . LXR modulators have been investigated as potential drugs in the therapy of cardiovascular diseases, metabolic syndrome, regulation of inflammatory response and immunity, skin diseases and are effective in the treatment of murine models of atherosclerosis, diabetes and Alzheimer's disease (Viennois et al., 2011 (Viennois et al., , 2012 Jakobsson et al., 2012) . Further, such agents have been shown to affect anti-inflammatory activity (Zhu & Bakovic, 2008; Zhu et al., 2012; Solan et al., 2011) and cell proliferation in a number of major cancer forms such as LNCaP human prostate cancer cells. (Viennois et al., 2012; Jakobsson et al., 2012) . The ligand-binding pocket (LBP) of LXR allows binding of side-chain-oxygenated sterols (OHCs). Recently, OHCs with a specific stereochemistry at the 23-hydroxyated side-chain carbon have also been shown to regulate the Hedgehog signalling pathway (Hh), a key developmental pathway playing multiple roles in embryonic development, including stem-cell differentiation (Corman et al., 2012) . In our drug-design programme, our retrosynthetic analysis for the establishment of synthetic routes to the pharmacophores in different OHCs revealed that the aldehyde analogue of the title compound [Fernholz aldehyde, (II)] is a key compound leading to a number of new library
Supramolecular features
The unit-cell and the molecular packing of (I) are shown in Fig. 2 . As a class, steroids display a pronounced tendency to form crystal structures with more than one molecule in the asymmetric unit; e.g. for about 35% of the 250 compounds mentioned above. The maximum Z 0 value of 16 is reached for the high-temperature polymorph of cholesterol itself (CHOEST21: Hsu et al., 2002) . Compound (I) has a Z 0 value of 2, the two molecules differing in the way the hydroxy groups make intermolecular hydrogen bonds (Table 1) (a) Unit-cell and crystal packing viewed along the a axis. The colour coding is as in Fig. 1 . The orange circles highlight a series of methyl groups; the blue area shades a hydrogen-bonded chain in shape of a flat helix. The chain, as a pink shape, is shown in more detail in (b) (the view is along the b axis).
Table 1
Hydrogen-bond geometry (Å , ). 
Synthesis and crystallization
Compound (I) (348 mg) was dissolved in a minimum amount of boiling EtOAc (40 ml). The flask containing the solution was wrapped in aluminium foil and left overnight at room temperature to afford colourless crystalline needles.
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . Coordinates were refined for hydroxyic H atoms; other H atoms were positioned with idealized geometry with fixed C-H = 0.95 (aromatic), 0.98 (methyl), 0.99 (methylene) or 1.00 Å (methine) Å . U iso values were set to 1.2U eq of the carrier atom, or 1.5U eq for methyl and hydroxy groups. Computer programs: APEX2 and SAINT-Plus (Bruker, 2013) , SHELXS2013 (Sheldrick, 2008) , SHELXL2013 (Sheldrick, 2015) and Mercury (Macrae et al., 2008) .
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Data collection: APEX2 (Bruker, 2013 ); cell refinement: SAINT-Plus (Bruker, 2013) ; data reduction: SAINT-Plus (Bruker, 2013 ); program(s) used to solve structure: SHELXS2013 (Sheldrick, 2008 ); program(s) used to refine structure:
SHELXL2013 (Sheldrick, 2015) ; molecular graphics: Mercury (Macrae et al., 2008) ; software used to prepare material for publication: SHELXL2013 (Sheldrick, 2015) . 
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